Open AccessMethod Comparison Between ELISAs Suggests Therapeutic Ranges for Infliximab Should Be Assay-Specific
Author(s) -
Mandy H. Perry,
Timothy J. McDonald
Publication year - 2018
Publication title -
the journal of applied laboratory medicine
Language(s) - English
Resource type - Journals
eISSN - 2576-9456
pISSN - 2475-7241
DOI - 10.1373/jalm.2018.027136
Subject(s) - infliximab , medicine , etiology , monoclonal antibody , tumor necrosis factor alpha , immunogenicity , gastroenterology , inflammatory bowel disease , immunology , antibody , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom